vimarsana.com
  1. Home
  2. Live Updates
  3. Meeting Of The European Society Hematology - Breaking News

Latest Breaking News On - Meeting of the european society hematology - Page 1 : vimarsana.com

Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

United statesRhui zhouHong kongEli lillyInnovent biologicsAdimab incyteJingwei yuMeeting of the european society hematologyChina hospital of sichuan universityMd anderson cancer centerPrnewswire innovent biologics incTianjin medical university cancer institute hospitalIncyte corporationAnnual meetingEuropean societyAbstract code

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.